MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MP-23-0009434
Neesi Pharmaceuticals Private Limited
Neesi Pharmaceuticals Private Limited - chemicals in Indore, Madhya Pradesh, India. Directors, charges & compliance details.
Revenue · FY 2023
₹3.78 Lakh
▲ 39% YoY
Net loss · FY 2023
₹19,047
Net margin -5%
EBITDA · FY 2023
-₹18,202
EBITDA margin -4.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2023
Balance sheet date
About Neesi Pharmaceuticals Private Limited
Data last updated:
Neesi Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the chemical products or preparations of a kind used in the textiles segment of the chemicals sector. It was incorporated on 11 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24297MP2020PTC054065.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Saurabh Kumar and Ritu Dubey.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at House No. 155 Sanskriti Peredise Pigdumber Rau, Indore, Madhya Pradesh, India – 453331.
As per the financials filed for FY 2023, the company reported a revenue of ₹3.78 Lakh, a growth of 39% compared to the previous year. For the same year it recorded a net loss of ₹19,047 (net margin -5%) and EBITDA of -₹18,202 (EBITDA margin -4.8%).
Neesi Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0009434).
Company Details of Neesi Pharmaceuticals Private Limited
CIN U24297MP2020PTC054065
Registration Number 054065
Incorporation Date 11 December 2020
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0009434
Key People
Saurabh Kumar Director Ritu Dubey Director Recognitions & Rankings of Neesi Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse No. 155 Sanskriti Peredise Pigdumber Rau, Indore, Madhya Pradesh, India – 453331
- IndustryChemicals, Chemical Products Or Preparations Of A Kind Used In The Textiles, Manufacturing, Other Chemical Product
Comprehensive company report
Neesi Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Neesi Pharmaceuticals Private Limited
The main business activity of Neesi Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Neesi Pharmaceuticals Private Limited FY 2023 filings available
Neesi Pharmaceuticals Private Limited reported revenue of ₹3.78 Lakh (up 39% YoY) for FY 2023.
Revenue · FY 2023
₹3.78 Lakh ▲ 39%
Net loss · FY 2023
₹19,047 margin -5%
EBITDA · FY 2023
-₹18,202 margin -4.8%
Compounded Annual Growth Rate (CAGR) of Neesi Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 39%
EBITDA CAGR growth
1 year
▲ 70%
Revenue rose 39% in the latest year. EBITDA rose 70% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Neesi Pharmaceuticals Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹18,202 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹19,047 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Neesi Pharmaceuticals Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -4.8% | •••• | •••• |
| Net Profit Margin | -5% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Neesi Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Neesi Pharmaceuticals Private Limited
Neesi Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saurabh Kumar | Director | 11 Dec 2020 | 5 Years 10 Months | Current |
| Ritu Dubey | Director | 11 Dec 2020 | 5 Years 10 Months | Current |
Peer Comparison of Neesi Pharmaceuticals Private Limited
Neesi Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Religence Pharmaceuticals Private Limited | ₹3.8 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Bhavnagar, Gujarat, India |
| Vidushi Pharmaceuticals Private Limited | ₹3.8 Lakh (FY 2022) | •••• | •••• | 2135.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Hesolt Pharmaceuticals Private Limited | ₹3.8 Lakh (FY 2020) | •••• | •••• | •••• | Navi Mumbai, Maharashtra, India | |
| Cognition Pharmaceuticals Private Limited | ₹3.79 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Yavatmal, Maharashtra, India |
| Rextone Pharmaceuticals Private Limited | ₹3.79 Lakh (FY 2025) | •••• | •••• | 41.0% | •••• | Ahmedabad, Gujarat, India |
| Neesi Pharmaceuticals Private Limited this company | ₹3.78 Lakh (FY 2023) | •••• | •••• | 39.0% | •••• | Indore, Madhya Pradesh, India |
| Valiant Pharmaceuticals Private Limited | ₹3.78 Lakh (FY 2024) | •••• | •••• | 84.0% | •••• | Kanpur, Uttar Pradesh, India |
| Twigg Pharmaceuticals Private Limited | ₹3.77 Lakh (FY 2022) | •••• | •••• | -19.0% | •••• | Mumbai, Maharashtra, India |
| Cresendo Pharmaceuticals Private Limited | ₹3.77 Lakh (FY 2023) | •••• | •••• | 146.0% | •••• | Hyderabad, Telangana, India |
| A R K Pharmaceuticals Private Limited | ₹3.77 Lakh (FY 2024) | •••• | •••• | -67.0% | •••• | Delhi, India |
| Eskal Pharmaceuticals Private Limited | ₹3.76 Lakh (FY 2025) | •••• | •••• | 28.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Neesi Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Neesi Pharmaceuticals Private Limited
Neesi Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Neesi Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Neesi Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Neesi Pharmaceuticals Private Limited
Neesi Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Ritu Dubey was appointed as Director on 11 Dec 2020.
AGM
Neesi Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Neesi Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Gwalior.
Appointed
Ritu Dubey was appointed as Director.
Appointed
Saurabh Kumar was appointed as Director.
Incorporation
11 Dec 2020
Neesi Pharmaceuticals Private Limited was registered on 11 Dec 2020 with Roc Gwalior & aged 5 years 10 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Neesi Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Neesi Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Neesi Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Neesi Pharmaceuticals Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Neesi Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neesi Pharmaceuticals Private Limited
Neesi Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in chemical products or preparations of a kind used in the textiles, within the chemicals industry. It was incorporated on 11 December 2020 (6+ years old) and is registered under CIN U24297MP2020PTC054065.
Neesi Pharmaceuticals reported revenue of ₹3.78 Lakh for FY 2023 (up 39% YoY).
Neesi Pharmaceuticals has 2 current directors:
- Saurabh Kumar - Director
- Ritu Dubey - Director
Neesi Pharmaceuticals reported a net loss of ₹19,047 (net margin -5%) and EBITDA of -₹18,202 (EBITDA margin -4.8%) for FY 2023, as per its filed financial statements.
The CIN (Corporate Identification Number) of Neesi Pharmaceuticals is U24297MP2020PTC054065. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neesi Pharmaceuticals was incorporated on 11 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Neesi Pharmaceuticals by revenue are Religence Pharmaceuticals Private Limited, Vidushi Pharmaceuticals Private Limited, Hesolt Pharmaceuticals Private Limited, Cognition Pharmaceuticals Private Limited, Rextone Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Ritu Dubey was appointed as Director on 11 Dec 2020. Saurabh Kumar was appointed as Director on 11 Dec 2020.
Yes, Neesi Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0009434).
The registered office of Neesi Pharmaceuticals is at House No. 155 Sanskriti Peredise Pigdumber Rau, Indore, Madhya Pradesh, India – 453331.
Neesi Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh.